HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The initiating factors of late preconditioning in skeletal muscle.

AbstractPURPOSE:
The goal of these studies was to determine the initiating factors for late preconditioning in the microcirculation of skeletal muscle.
MATERIALS AND METHODS:
The cremaster muscle of male Sprague-Dawley rats underwent 4 h of ischemia and then 60 min of reperfusion. Ischemic preconditioning (IPC) consisted of 45 min of ischemia but was done 24 h before the 4 h of ischemia. To mimic the effects of IPC in the late phase, adenosine (ADO) or sodium nitroprusside (SNP) was given 24 h before the prolonged ischemia via local intraarterial infusion. To block the effects of IPC in the late phase, 8-sulfophenyl-theophylline (a nonspecific ADO receptor blocker) or N(W)-nitro-l-arginine (a nonselective nitric oxide synthase antagonist) was given prior to IPC. Microvascular response to IPC and pharmacological preconditioning were determined by measuring arteriole diameters and capillary perfusion using intravital microscopy.
RESULTS:
Administration of ADO or SNP on day 1 without IPC produced a similar microvascular protection against prolonged ischemia/reperfusion on day 2 as that induced by IPC alone. In contrast, blocking ADO receptors or nitric oxide synthase on day 1 just prior to IPC eliminated the IPC-induced microvascular protection seen on day 2. In addition, inhibition of nitric oxide synthase on day 1 diminished the protection induced by ADO, but blocking ADO receptors on day 1 did not compromise the protection induced by SNP.
CONCLUSION:
The results from these studies suggest that up regulation of ADO is the initiating factor with secondary up regulation of nitric oxide in late preconditioning. Both ADO and nitric oxide contribute to initiating microvascular protection in the late phase of IPC.
AuthorsW Z Wang, S Z Guo, G L Anderson, F N Miller
JournalThe Journal of surgical research (J Surg Res) Vol. 99 Issue 1 Pg. 92-9 (Jul 2001) ISSN: 0022-4804 [Print] United States
PMID11421609 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
CopyrightCopyright 2001 Academic Press.
Chemical References
  • Enzyme Inhibitors
  • Purinergic P1 Receptor Antagonists
  • Vasodilator Agents
  • Nitroprusside
  • Nitric Oxide Synthase
  • Adenosine
Topics
  • Adenosine (pharmacology)
  • Animals
  • Arterioles (drug effects, physiopathology)
  • Capillaries (drug effects, physiopathology)
  • Enzyme Inhibitors (pharmacology)
  • Ischemic Preconditioning
  • Male
  • Muscle, Skeletal (blood supply, drug effects, physiopathology)
  • Nitric Oxide Synthase (antagonists & inhibitors)
  • Nitroprusside (pharmacology)
  • Purinergic P1 Receptor Antagonists
  • Rats
  • Rats, Sprague-Dawley
  • Time Factors
  • Vasodilator Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: